[HTML][HTML] Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and …
CWM Ong, GB Migliori, M Raviglione… - European …, 2020 - Eur Respiratory Soc
Major epidemics, including some that qualify as pandemics, such as severe acute
respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), HIV, influenza A …
respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), HIV, influenza A …
QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis
Estimated 2017 tuberculosis (TB) incidence is 10 million and mainly depends on the
reservoir of individuals with latent TB infection (LTBI). QuantiferonⓇ-TB Gold in-Tube (QFT …
reservoir of individuals with latent TB infection (LTBI). QuantiferonⓇ-TB Gold in-Tube (QFT …
[HTML][HTML] Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2
Objectives The interaction of COVID-19 and tuberculosis (TB) are still poor characterized.
Here we evaluated the immune response specific for Micobacterium tuberculosis (Mtb) and …
Here we evaluated the immune response specific for Micobacterium tuberculosis (Mtb) and …
[HTML][HTML] Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients
Objectives To identify the best experimental approach to detect a SARS-CoV-2-specific T
cell response using a whole-blood platform. Methods Whole-blood from 56 COVID-19 and …
cell response using a whole-blood platform. Methods Whole-blood from 56 COVID-19 and …
Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis molecular bacterial load assay
In this comparative biomarker study, we analysed 1768 serial sputum samples from 178
patients at 4 sites in Southeast Africa. We show that tuberculosis Molecular Bacterial Load …
patients at 4 sites in Southeast Africa. We show that tuberculosis Molecular Bacterial Load …
Biomarkers that correlate with active pulmonary tuberculosis treatment response: a systematic review and meta-analysis
AJ Zimmer, F Lainati, N Aguilera Vasquez… - Journal of clinical …, 2022 - Am Soc Microbiol
Current WHO recommendations for monitoring treatment response in adult pulmonary
tuberculosis (TB) are sputum smear microscopy and/or culture conversion at the end of the …
tuberculosis (TB) are sputum smear microscopy and/or culture conversion at the end of the …
[HTML][HTML] Antibody subclass and glycosylation shift following effective TB treatment
PS Grace, S Dolatshahi, LL Lu, A Cain… - Frontiers in …, 2021 - frontiersin.org
With an estimated 25% of the global population infected with Mycobacterium tuberculosis
(Mtb), tuberculosis (TB) remains a leading cause of death by infectious diseases. Humoral …
(Mtb), tuberculosis (TB) remains a leading cause of death by infectious diseases. Humoral …
[HTML][HTML] Tools to implement the World Health Organization End TB Strategy: Addressing common challenges in high and low endemic countries
Aim The purpose of this viewpoint is to summarize the advantages and constraints of the
tools and strategies available for reducing the annual incidence of tuberculosis (TB) by …
tools and strategies available for reducing the annual incidence of tuberculosis (TB) by …
Disease extent and anti‐tubercular treatment response correlates with Mycobacterium tuberculosis‐specific CD4 T‐cell phenotype regardless of HIV‐1 status
Objectives The development of non‐sputum‐based assays for tuberculosis (TB) diagnosis
and treatment monitoring is a key priority. Recent data indicate that whole blood‐based …
and treatment monitoring is a key priority. Recent data indicate that whole blood‐based …
[HTML][HTML] Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring
R Bayaa, MDB Ndiaye, C Chedid, E Kokhreidze… - Scientific Reports, 2021 - nature.com
There is a crucial need for non-sputum-based TB tests. Here, we evaluate the performance
of RISK6, a human-blood transcriptomic signature, for TB screening, triage and treatment …
of RISK6, a human-blood transcriptomic signature, for TB screening, triage and treatment …